Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J T Lundquist

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Bioorganic & Medicinal Chemistry Letters|September 25, 1999
Preparation and receptor binding affinities of cyclic C-terminal neurotensin (8-13) and (9-13) analoguesJ T Lundquist, T A Dix
Organic Letters|March 22, 2001
Improved solid-phase peptide synthesis method utilizing alpha-azide-protected amino acidsJ T Lundquist, J C Pelletier
Journal of Medicinal Chemistry|December 2, 1999
Synthesis and human neurotensin receptor binding activities of neurotensin(8-13) analogues containing position 8 alpha-azido-N-alkylated derivatives of ornithine, lysine, and homolysineJ T Lundquist, T A Dix
Bioorganic & Medicinal Chemistry Letters|April 1, 2000
Synthesis of neurotensin(9-13) analogues exhibiting enhanced human neurotensin receptor binding affinitiesJ T Lundquist, E E Büllesbach, T A Dix
The Journal of Peptide Research : Official Journal of the American Peptide Society|March 22, 2002
Topography of the neurotensin (NT)(8-9) binding site of human NT receptor-1 probed with NT(8-13) analogsJ T Lundquist, E E Büllesbach, P L Golden, et al.
The Journal of Peptide Research : Official Journal of the American Peptide Society|May 8, 2000
Design rationale, synthesis, and characterization of non-natural analogs of the cationic amino acids arginine and lysineK J Kennedy, J T Lundquist, T L Simandan, et al.
Harvard Business Review|August 6, 1993
Strategy and the art of reinventing valueK van der Heijden, M Maccoby, N Hama, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Bioorganic & Medicinal Chemistry Letters|September 25, 1999
Preparation and receptor binding affinities of cyclic C-terminal neurotensin (8-13) and (9-13) analoguesJ T Lundquist, T A Dix
Organic Letters|March 22, 2001
Improved solid-phase peptide synthesis method utilizing alpha-azide-protected amino acidsJ T Lundquist, J C Pelletier
Journal of Medicinal Chemistry|December 2, 1999
Synthesis and human neurotensin receptor binding activities of neurotensin(8-13) analogues containing position 8 alpha-azido-N-alkylated derivatives of ornithine, lysine, and homolysineJ T Lundquist, T A Dix
Bioorganic & Medicinal Chemistry Letters|April 1, 2000
Synthesis of neurotensin(9-13) analogues exhibiting enhanced human neurotensin receptor binding affinitiesJ T Lundquist, E E Büllesbach, T A Dix
The Journal of Peptide Research : Official Journal of the American Peptide Society|March 22, 2002
Topography of the neurotensin (NT)(8-9) binding site of human NT receptor-1 probed with NT(8-13) analogsJ T Lundquist, E E Büllesbach, P L Golden, et al.
The Journal of Peptide Research : Official Journal of the American Peptide Society|May 8, 2000
Design rationale, synthesis, and characterization of non-natural analogs of the cationic amino acids arginine and lysineK J Kennedy, J T Lundquist, T L Simandan, et al.
Harvard Business Review|August 6, 1993
Strategy and the art of reinventing valueK van der Heijden, M Maccoby, N Hama, et al.
Pageof 1